A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Incyte Corporation
Baylor College of Medicine
Mayo Clinic
Seagen Inc.
Pfizer
National Institutes of Health Clinical Center (CC)
Canadian Cancer Trials Group